Clinical Study

High Complement Factor I Activity in the Plasma of Children with Autism Spectrum Disorders

Figure 2

(a) Complement factor I activity in EDTA plasma from children with ASD ( ) and healthy control children ( ). A scatter plot of factor I activity for each individual is shown. Samples from ASD children who were not under medication at the time of the investigation, those under medication with Risperdal, Ritalin, a combination thereof, or other medications such as antipsychotics (thioridazine) or anticonvulsants (fenobarbital and sodium valproate) are shown. (b) Mean values and standard errors of the complement factor I activity in EDTA plasma are shown for the different age groups and genders for both children with ASD and the healthy control group. In the ASD group; age ≤ 5 years: males ( ), females ( ) and age > 5 years: males ( ), females ( ). In the healthy control group; age ≤ 5 years: males ( ), females ( ) and age > 5 years: males ( ), females ( ).
868576.fig.002a
(a)
868576.fig.002b
(b)